Retraction notices

Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung

Type

Retraction

Notice date

7/19/2023 0:00

Journal

Computational Intelligence and Neuroscience

Publisher

Hindawi

Notice DOI

10.1155/2023/9879124

Original paper DOI

10.1155/2022/3137370

Reasons

• Concerns/Issues about Data
• Concerns/Issues about Results and/or Conclusions
• Concerns/Issues about Referencing/Attributions
• Concerns/Issues about Peer Review
• Informed/Patient Consent - None/Withdrawn
• Investigation by Journal/Publisher
• Investigation by Third Party
• Lack of IRB/IACUC Approval and/or Compliance
• Paper Mill
• Computer-Aided Content or Computer-Generated Content
• Unreliable Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• Computational Intelligence and Neuroscience